These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10521545)

  • 1. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone.
    Boylan MT; Crockard AD; McDonnell GV; Armstrong MA; Hawkins SA
    J Neurol Sci; 1999 Aug; 167(2):79-89. PubMed ID: 10521545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.
    Filion LG; Matusevicius D; Graziani-Bowering GM; Kumar A; Freedman MS
    Clin Immunol; 2003 Feb; 106(2):127-38. PubMed ID: 12672403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'immunological-synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta.
    Shapiro S; Galboiz Y; Lahat N; Kinarty A; Miller A
    J Neuroimmunol; 2003 Nov; 144(1-2):116-24. PubMed ID: 14597105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus.
    Liu MF; Li JS; Weng TH; Lei HY
    Scand J Immunol; 1999 Jan; 49(1):82-7. PubMed ID: 10023862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes.
    Fischer HJ; Finck TLK; Pellkofer HL; Reichardt HM; Lühder F
    Front Immunol; 2019; 10():1200. PubMed ID: 31191554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).
    Balabanov R; Lisak D; Beaumont T; Lisak RP; Dore-Duffy P
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1196-203. PubMed ID: 11687463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
    Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
    Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis.
    Mena E; Rohowsky-Kochan C
    Acta Neurol Scand; 1999 Aug; 100(2):92-6. PubMed ID: 10442449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
    Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
    Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
    Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
    Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect.
    Girndt M; Sester M; Sester U; Kaul H; Köhler H
    Kidney Int; 2001 Apr; 59(4):1382-9. PubMed ID: 11260399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients.
    Folzenlogen D; Hofer MF; Leung DY; Freed JH; Newell MK
    Clin Immunol Immunopathol; 1997 Jun; 83(3):199-204. PubMed ID: 9175908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.
    Köchli C; Wendland T; Frutig K; Grunow R; Merlin S; Pichler WJ
    Immunol Lett; 1999 Feb; 65(3):197-201. PubMed ID: 10065743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes in multiple sclerosis: phenotype and cytokine profile.
    Kouwenhoven M; Teleshova N; Ozenci V; Press R; Link H
    J Neuroimmunol; 2001 Jan; 112(1-2):197-205. PubMed ID: 11108949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
    Moosig F; Csernok E; Wang G; Gross WL
    Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta-1b.
    Jensen MA; Yanowitch RN; Reder AT; White DM; Arnason BG
    Mult Scler; 2010 Jan; 16(1):30-8. PubMed ID: 20007427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer.
    Luczynski W; Stasiak-Barmuta A; Krawczuk-Rybak M
    Cancer Immunol Immunother; 2004 Nov; 53(11):1049-50. PubMed ID: 15449044
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of interferon-beta on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis.
    Wiesemann E; Deb M; Trebst C; Hemmer B; Stangel M; Windhagen A
    Mult Scler; 2008 Mar; 14(2):166-76. PubMed ID: 17942524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.